References
- Kreisman H, Ginsberg S, Propert KJ, Richards F, Graziano S, Green M, Carboplatin or iproplatin in advanced NSCLC: a Cancer and Leukemia Group B study. Cancer Treat Rep 1987; 71: 1049.
- Natale RB, Gralla RJ, Wittes RE, Golbey RB, Young CW. Vindesine chemotherapy in lung cancer. Cancer Treat Rev 1980; 7(suppl): 59.
- Gralla RJ, Casper ES, Kelsen DP, et al. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern Med 1981; 95: 414.
- Carmichael J, Gregor A, Cornbleet MA, et al. Cisplatinum and vindesine in combination in the treatment of non-small cell lung cancer. Eur J Cancer Clin Oncol 1985; 21: 811.
- Devogelaere R. Cisplatin (CDDP) and vindesine (VDS) in non small cell lung cancer: A multicenter trial. Proc. ECCO-4, p 14, Madrid 1987 (abstr).
- Dhingra HM, Valdivieso M, Carr DT, et al. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer. J Clin Oncol 1985; 3: 176.
- Einhorn LH, Loehrer PJ, Williams SD, et al. Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin-c in advanced non-small-cell lung cancer. J Clin Oncol 1986; 4: 1037.
- Hainsworth JD, Johnson DH, Hande KR, Greco FA. Chemotherapy of advanced non-small-cell lung cancer: A randomized trial of three cisplatin-based chemotherapy regimens. Am J Clin Oncol 1989; 12: 345.
- Kris MG, Gralla RJ, Kalman LA, et al. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment. Cancer Treat Rep 1985; 69: 387.
- Kudoh S, Fukuoka M, Negoro S, Furuse K, Kawahara M. A randomized trial in advanced non-small cell lung cancer (NSCLC): cisplatin (C) and vindesine (V) vs cisplatin, vindesine and mitomycin (M) vs cisplatin and etoposide (E) alternating with vindesine and mitomycin. Proc Am Soc Clin Oncol (abstr) 1990; 9: A880.
- Luedke DW, Einhorn L, Omura GA, Sarma PR, Bartolucci AA, Birch R, Greco FA. Randomized comparison of two combination regimens versus minimal chemotherapy in non-small-cell lung cancer: A Southeastern Cancer Study Group Trial: J Clin Oncol 1990; 8:886.
- Paccagnella A, Brandes A, Pappagallo GL, et al. Cisplatin plus vindesine versus cisplatin plus VP16 versus doxorubicin plus Cytoxan in non-small-cell carcinoma of the lung. A randomized study. Tumori 1986; 72: 417.
- Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer - Report of a Canadian multicenter randomized trial. J Clin Oncol 1988 6: 633.
- Ruckdeschel JC, Finklstein DM, Ettinger DS, Creech RH, Mason BA, Joss RA, Vogl S. A randomized trial of the four most active regimens four metastatic non-small-cell lung cancer. J Clin Oncol 1986; 4: 14.
- Woods RL, Williams CJ, Levi J, Page J, Bell D, Byrne M, Kerestes ZL. A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 1990; 61: 608.
- Martini N, Kris MG, Gralla R J, et al. The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0). Ann Thorac Surg 1988; 45: 370:
- Tourani JM, Timsit JF, Delaisement C, et al. Two cycles of cisplatin-vindesine and radiotherapy for localized non-small cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patients. Cancer 1990; 65: 1472.